Page last updated: 2024-08-21

perfluorooctanoic acid and Non-alcoholic Fatty Liver Disease

perfluorooctanoic acid has been researched along with Non-alcoholic Fatty Liver Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Attema, B; Hooiveld, GJEJ; Janssen, AWF; Kersten, S; Rijkers, D; van Schothorst, EM1
Arthur, E; Gadi, S; Kumar, D; Levine, KE; Moore, J; Niture, S; Qi, Q1
Dunder, L; Elmståhl, S; Lind, L; Lind, PM; Salihovic, S1
An, H; Ao, L; Cao, J; Chen, Q; Cui, H; He, S; Ling, X; Liu, J; Wang, L; Yang, W; Yang, Z; Zou, P1
Klaunig, JE; Li, X; Wang, Z1

Other Studies

5 other study(ies) available for perfluorooctanoic acid and Non-alcoholic Fatty Liver Disease

ArticleYear
Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice.
    Molecular metabolism, 2022, Volume: 66

    Topics: Animals; Body Weight; Fluorocarbons; Glucose; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; PPAR alpha; Transcriptome; Triglycerides

2022
Per- and polyfluoroalkyl substances activate UPR pathway, induce steatosis and fibrosis in liver cells.
    Environmental toxicology, 2023, Volume: 38, Issue:1

    Topics: Alkanesulfonic Acids; Environmental Pollutants; Fibrosis; Fluorocarbons; Humans; Non-alcoholic Fatty Liver Disease; Unfolded Protein Response

2023
Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Journal of exposure science & environmental epidemiology, 2023, Volume: 33, Issue:5

    Topics: Alkanesulfonic Acids; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Environmental Pollutants; Female; Fluorocarbons; Glucose; Humans; Longitudinal Studies; Male; Non-alcoholic Fatty Liver Disease; Obesity; Sweden

2023
PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Environment international, 2023, Volume: 178

    Topics: Alkanesulfonic Acids; Animals; Caprylates; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Environmental Pollutants; Fluorocarbons; Humans; Lipid Metabolism; Lipid Metabolism Disorders; Mice; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; PPAR alpha; Rats

2023
The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Toxicology, 2019, 03-15, Volume: 416

    Topics: Animals; Caprylates; Cell Proliferation; Chemical and Drug Induced Liver Injury; Constitutive Androstane Receptor; Cytochrome P-450 Enzyme System; Diet, High-Fat; Disease Models, Animal; Disease Progression; Environmental Pollutants; Fluorocarbons; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; PPAR alpha; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Risk Assessment; Signal Transduction; Time Factors

2019